Fosun Pharma Closes $90 Million Acquisition of Sweden's Breas Medical

Fosun Pharma has completed its $90 million purchase of an 80% stake in Swedish device company Breas Medical Group. Breas makes homecare ventilation and sleep apnea devices, which it markets in Europe and the US. Fosun intends to bring the products to China. Fosun bought the stake from PBM Capital, a venture investor. PBM put the company together by acquiring three separate ventilation and apnea device companies, which it operated under the name Breas Medical Group. More details.... Stock Symbol: (SHA: 600196; HK: 2196) Share this with colleagues: // //